| Identification | Back Directory | [Name]
N1-(6-ethoxypyridazin-3-yl)sulphanilamide | [CAS]
963-14-4 | [Synonyms]
SULFAETHOXYPYRIDAZIN
Sulfaethoxypyridazine
Sulfaethoxypyridazine Standard
N1-(6-ethoxypyridazin-3-yl)sulphanilamide
N(1)-(6-ethoxypyridazin-3-yl)sulfanilamid
4-amino-N-(6-ethoxypyridazin-3-yl)benzenesulfonamide
4-Amino-N-(6-ethoxy-3-pyridazinyl)benzenesulfonamide
4-azanyl-N-(6-ethoxypyridazin-3-yl)benzenesulfonamide
Benzenesulfonamide, 4-amino-N-(6-ethoxy-3-pyridazinyl)-
Sulfaethoxypyridazine Solution in Acetonitrile, 100μg/mL
N1-(6-ethoxypyridazin-3-yl)sulphanilamide ISO 9001：2015 REACH
4-Amino-N-(6-ethoxy-3-pyridazinyl)benzenesulfonamide, N1-(6-Ethoxy-3-pyridazinyl)sulfanilamide
Sulfaethoxypyridazine,4-Amino-N-(6-ethoxy-3-pyridazinyl)benzenesulfonamide, N1-(6-Ethoxy-3-pyridazinyl)sulfanilamide | [EINECS(EC#)]
213-514-7 | [Molecular Formula]
C12H14N4O3S | [MDL Number]
MFCD00869228 | [MOL File]
963-14-4.mol | [Molecular Weight]
294.33 |
| Chemical Properties | Back Directory | [Melting point ]
182-184 °C | [Boiling point ]
565.9±60.0 °C(Predicted) | [density ]
1.416±0.06 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
7.24±0.30(Predicted) | [color ]
Off-White to Light Brown | [CAS DataBase Reference]
963-14-4 |
| Hazard Information | Back Directory | [Chemical Properties]
Crystals. Soluble in
water at 37?. | [Uses]
Sulfaethoxypyridazine is a sulfonamide that is used in veterinary medicine as feedstuffs, and in human medicines in the treatment of systematic infections. | [Definition]
ChEBI: Sulfaethoxypyridazine is a sulfonamide consisting of 6-ethoxypyridazine with a 4-aminobenzenesulfonamido group at the 3-position. Generally licensed for veterinary use only against bacterial infections, such as fowl cholera and salmonella infection. It has a role as an antibacterial agent. | [in vivo]
Feeding of Sulfaethoxypyridazine, a long-acting sulfonamide, to rats at dietary levels of 800, 1600, and 3200 ppm resulted in the development of characteristic lens opacities by 23 weeks. Daily oral administration of 30, 67, and 150 mg/kg to dogs resulted in the development of similar cataracts by 14 weeks[1]. |
| Safety Data | Back Directory | [WGK Germany ]
3 | [RTECS ]
WO9410000 | [Safety Profile]
When heated to decomposition it emits acrid smoke and irritating fumes. |
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Website: |
https://www.alfa-chemistry.com |
|